Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
featured
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Gantenerumab in Patients with Early [Prodromal to Mild] Alzheimer's Disease

Studies the effect of a new drug in Early Alzheimer's

mini-mental state examination
  • 34 views
  • 08 Dec, 2020
  • 1 location
featured
Mild Dementia/Alzheimer's Disease

Mild Dementia/Alzheimer's Disease

  • 474 views
  • 08 Dec, 2020
  • 1 location
featured
Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.

Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.

  • 104 views
  • 08 Dec, 2020
  • 1 location
featured
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

Alzheimer's Disease

  • 82 views
  • 08 Dec, 2020
  • 1 location
featured
Alzheimer’s Disease Study

with mild Alzheimer’s Disease.  

  • 35 views
  • 08 Dec, 2020
  • 1 location
featured
[ONLINE] Alzheimer's Disease Center Research Registry

This study is looking for people over the age of 55 who have normal cognition, memory problems, or mild dementia. The study is also looking for people who are care partners of someone who has

mild dementia
  • 124 views
  • 06 Oct, 2020
  • 253 locations
featured
Is your memory loss just a sign of age, or something else?

Is your memory loss just a sign of age, or something else?

  • 330 views
  • 08 Dec, 2020
  • 1 location
featured
Alzheimer's Disease

Alzheimer's Disease

  • 118 views
  • 08 Dec, 2020
  • 1 location
A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD

glutaminyl cyclase enzyme, in 250 subjects with mild cognitive impairment and mild dementia due to Alzheimer 's Disease.

  • 0 views
  • 13 Dec, 2020
  • 10 locations
High-dose Vitamin D Supplements in Older Adults

brain MRI scans will be enrolled, with 152 (~50 with MCI, 50 with mild AD and 50 with no cognitive impairment) expected to complete the 3-year study. One-half of each diagnostic group will be randomized

  • 0 views
  • 23 Nov, 2020
  • 1 location